Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.
作者： Vittoria Colia , Salvatore Provenzano , Nadia Hindi , Paolo G. Casali , Silvia Stacchiotti
DOI: 10.1016/J.RPOR.2015.12.005
关键词:
摘要: This review highlights the data currently available on activity of systemic therapy in chondrosarcoma, chordoma, giant cell tumour bone (GCTB) and solitary fibrous tumour, i.e., four rare sarcomas amongst mesenchymal malignancy arising from skull base.
elsevier.com
sci-hub.se 参考文章(66)
Orin Bloch, Andrew T. Parsa, Skull Base Chondrosarcoma: Evidence-Based Treatment Paradigms Neurosurgery Clinics of North America. ,vol. 24, pp. 89- 96 ,(2013) , 10.1016/J.NEC.2012.08.002
JA Bridge, Christopher Fletcher, Fredrik Mertens, Pcw Hogendoorn, WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, vol. 5 World Health Organization. ,(2013)
Annemiek M. van Maldegem, Hans Gelderblom, Emanuela Palmerini, Sander D. Dijkstra, Marco Gambarotti, Pietro Ruggieri, Remi A. Nout, Michiel A. J. van de Sande, Cristina Ferrari, Stefano Ferrari, Judith V. M. G. Bovée, Piero Picci, Outcome of advanced, unresectable conventional central chondrosarcoma. Cancer. ,vol. 120, pp. 3159- 3164 ,(2014) , 10.1002/CNCR.28845
Piotr Rutkowski, Stefano Ferrari, Robert J. Grimer, Paul D. Stalley, Sander P. D. Dijkstra, Andrzej Pienkowski, Gualter Vaz, Jay S. Wunder, Leanne L. Seeger, Amy Feng, Zachary J. Roberts, Bruce A. Bach, Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone Annals of Surgical Oncology. ,vol. 22, pp. 2860- 2868 ,(2015) , 10.1245/S10434-015-4634-9
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Min S. Park, Shreyaskumar R. Patel, Joseph A. Ludwig, Jonathan C. Trent, Charles A. Conrad, Alexander J. Lazar, Wei-Lien Wang, Piyaporn Boonsirikamchai, Haesun Choi, Xuemei Wang, Robert S. Benjamin, Dejka M. Araujo, Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor Cancer. ,vol. 117, pp. 4939- 4947 ,(2011) , 10.1002/CNCR.26098
T. Valentin, C. Fournier, N. Penel, E. Bompas, L. Chaigneau, N. Isambert, C. Chevreau, Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO) Investigational New Drugs. ,vol. 31, pp. 1626- 1627 ,(2013) , 10.1007/S10637-013-0023-Z
Fergal C. Kelleher, Jason E. Cain, Joan M. Healy, D. Neil Watkins, David M. Thomas, Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacology & Therapeutics. ,vol. 136, pp. 153- 168 ,(2012) , 10.1016/J.PHARMTHERA.2012.08.004
David J. Stewart, Raymond Belanger, and Robert S. Benjamin, Prolonged disease-free survival following surgical debulking and high-dose cisplatin/doxorubicin in a patient with bulky metastases from giant cell tumor of bone refractory to "standard" chemotherapy. American Journal of Clinical Oncology. ,vol. 18, pp. 144- 148 ,(1995) , 10.1097/00000421-199504000-00010
Orin Bloch, Michael E. Sughrue, Steven A. Mills, Andrew T. Parsa, Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy Journal of Clinical Neuroscience. ,vol. 18, pp. 881- 885 ,(2011) , 10.1016/J.JOCN.2010.09.025